Á¦37Â÷ ´ëÇÑ´ç´¢º´ÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-03
±³À°ÀÏÀÚ : 2024-05-03
±³À°Àå¼Ò : â¿øÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ : Á¦37Â÷ ´ëÇÑ´ç´¢º´ÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : ÀÌ¿¬ÁÖ
¿¬¶ôó : 02-714-9071
À̸ÞÀÏ : diabetes@kams.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 1200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : °æ»ó³²µµ
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 250,000¿ø
ºñ°í "Àü¹®ÀÇ: »çÀü ȸ¿ø 140,000¿ø, ÇöÀå ȸ¿ø, 200,000¿ø / »çÀü ºñȸ¿ø 200,000¿ø, ÇöÀå ºñȸ¿ø 250,000¿øÀü°øÀÇ ¹× ºñÀÇ»ç: »çÀü ȸ¿ø 70,000¿ø, ÇöÀå ȸ¿ø100,000¿ø / »çÀü ºñȸ¿ø 120,000¿ø, ÇöÀå ºñȸ¿ø 150,000¿ø"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room1 08:20~08:50 What's new in T2D? Dapa + Sita combination! ±èÈÖ½Â(Áß¾ÓÀÇ´ë ³»°ú)
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room4 09:00~09:20 Recent advance in anti-obesity medication ±¸º¸°æ(¼¿ïÀÇ´ë ³»°ú)
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room4 09:20~09:40 Eat deliciously and lose weight healthily! application of healthy eating patterns Á¤À±¹Ì(°æÈñÀÇ·á¿ø ¿µ¾çÆÀ)
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room4 09:40~10:00 Exercise recommendations for obese individuals with diabetes Á¤½ÂÀç(»ï»ó¼¿ïº´¿ø ½ºÆ÷Ã÷ÀÇÇнÇ)
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room4 10:00~10:20 Social work intervention for patients with obesity À̸í¼÷(°è¸í´ëÇб³ µ¿»êº´¿ø »çȸ»ç¾÷ÆÀ)
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room 1,2,3 10:50~11:30 Lessons and challenges learned from long-term diabetes clinical research funded by Korean government ¿ìÁ¤ÅÃ(°æÈñÀÇ´ë ³»°ú)
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room2 11:50~12:05 SGLT2i, expanding horizons for CRM treatment Á¤Ã¢Èñ(¿ï»êÀÇ´ë ³»°ú)
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room1 12:05~12:20 Latest update on the patient benefit of switching to FRC from other injection therapy ÀÌÀºÁ¤(¼º±Õ°üÀÇ´ë ³»°ú)
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room 1,2,3 13:20~14:00 Obesity, insulin resistance, inflammation, type 2 diabetes, immunometabolism ÀÌÁ¾¼ø(¼øõÇâÀÇ»ý¸í¿¬±¸¿ø)
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room3 14:20~14:50 My journey through storm: lessons for the next chapter Á¤Àº°æ(¼¿ïÀÇ´ë °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room3 14:50~15:00 Diabetes and COVID-19: a bidirectional interplay ¹®Áؼº(¿µ³²ÀÇ´ë ³»°ú)
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room3 15:00~15:10 Effect of COVID-19 on the emergency care of diabetes ·ùÇýÁø(°í·ÁÀÇ´ë ³»°ú)
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room3 15:10~15:20 The role of telemedicine in next pandemic preparedness Á¶ÀçÇü(°¡Å縯ÀÇ´ë ³»°ú)
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room1 16:40~17:00 Next chapter of MDI: smart insulin pen to reduce patient burden Áø»ó¸¸(¼º±Õ°üÀÇ´ë ³»°ú)
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room1 17:00~17:20 Weekly insulin: pharmacokinetics/dosing strategy and clinical outcome Á¶À±°æ(¿ï»êÀÇ´ë ³»°ú)
±³À°½Ã°£ 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room1 17:20~17:40 Next chapter of AID: carb counting or not - either is fine? ¹®¼±ÁØ(¼º±Õ°üÀÇ´ë ³»°ú)
Åä·Ð 05¿ù 03ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ Room1 17:40~18:00 Panel discussion À̵¿¿ø ±Ç¼ÒÀ± À¯ÁöÈñ(ºÎ»êÀÇ´ë ³»°ú ´ë±¸°¡Å縯ÀÇ´ë ³»°ú Áß¾ÓÀÇ´ë ³»°ú)